BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 25681288)

  • 21. Potentiation of mitomycin C tumoricidal activity for transitional cell carcinoma by histone deacetylase inhibitors in vitro.
    Deb AA; Wilson SS; Rove KO; Kumar B; Koul S; Lim DD; Meacham RB; Koul HK
    J Urol; 2011 Dec; 186(6):2426-33. PubMed ID: 22019171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Silencing survivin expression inhibits the tumor growth of non-small-cell lung cancer cells in vitro and in vivo.
    Zhang K; Li Y; Liu W; Gao X; Zhang K
    Mol Med Rep; 2015 Jan; 11(1):639-44. PubMed ID: 25333812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. siRNA-mediated down-regulation of survivin inhibits bladder cancer cell growth.
    Ning S; Fuessel S; Kotzsch M; Kraemer K; Kappler M; Schmidt U; Taubert H; Wirth MP; Meye A
    Int J Oncol; 2004 Oct; 25(4):1065-71. PubMed ID: 15375557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic efficacy of a lipid-based prodrug of mitomycin C in pegylated liposomes: studies with human gastro-entero-pancreatic ectopic tumor models.
    Gabizon A; Amitay Y; Tzemach D; Gorin J; Shmeeda H; Zalipsky S
    J Control Release; 2012 Jun; 160(2):245-53. PubMed ID: 22134116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cytotoxic effect of oncolytic virus combined with mitomycin against human bladder cancer cells in vitro and in vivo].
    Zhao GZ; Tan WL; Zheng SB; Wu YD; Xie Y; Zhu WH
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Nov; 26(11):1623-5, 1628. PubMed ID: 17121717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survivin knockdown by short hairpin RNA abrogates the growth of human hepatocellular carcinoma xenografts in nude mice.
    Zhang R; Ma L; Zheng M; Ren J; Wang T; Meng Y; Zhao J; Jia L; Yao L; Han H; Li K; Yang A
    Cancer Gene Ther; 2010 Apr; 17(4):275-88. PubMed ID: 19876077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Growth inhibition induced by short hairpin RNA to silence survivin gene in human pancreatic cancer cells.
    Shen YM; Yang XC; Song ML; Qin CH; Yang C; Sun YH
    Hepatobiliary Pancreat Dis Int; 2010 Feb; 9(1):69-77. PubMed ID: 20133233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Knockdown of survivin expression by siRNAs enhances chemosensitivity of prostate cancer cells and attenuates its tumorigenicity.
    Shen J; Liu J; Long Y; Miao Y; Su M; Zhang Q; Han H; Hao X
    Acta Biochim Biophys Sin (Shanghai); 2009 Mar; 41(3):223-30. PubMed ID: 19280061
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravesical chemotherapy of high-grade bladder cancer with HTI-286, a synthetic analogue of the marine sponge product hemiasterlin.
    Hadaschik BA; Adomat H; Fazli L; Fradet Y; Andersen RJ; Gleave ME; So AI
    Clin Cancer Res; 2008 Mar; 14(5):1510-8. PubMed ID: 18316576
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synergistic effects of 7-O-geranylquercetin and siRNAs on the treatment of human breast cancer.
    Zuo J; Jiang Y; Zhang E; Chen Y; Liang Z; Zhu J; Zhao Y; Xu H; Liu G; Liu J; Wang W; Zhang S; Zhen Y
    Life Sci; 2019 Jun; 227():145-152. PubMed ID: 31009625
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeted gene delivery in tumor xenografts by the combination of ultrasound-targeted microbubble destruction and polyethylenimine to inhibit survivin gene expression and induce apoptosis.
    Chen ZY; Liang K; Qiu RX
    J Exp Clin Cancer Res; 2010 Nov; 29(1):152. PubMed ID: 21092274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel Survivin-Targeted Small Interfering RNA Delivered by Nanoparticles.
    Feng C; Wang T; Zhang Y; Qu K; Tang S
    Am J Med Sci; 2017 Nov; 354(5):506-512. PubMed ID: 29173363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sensitization of human bladder cancer cells to Fas-mediated cytotoxicity by cis-diamminedichloroplatinum (II).
    Mizutani Y; Yoshida O; Bonavida B
    J Urol; 1998 Aug; 160(2):561-70. PubMed ID: 9679929
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Galactosylated poly(ethylene glycol) methacrylate-st-3-guanidinopropyl methacrylamide copolymers as siRNA carriers for inhibiting Survivin expression in vitro and in vivo.
    Wu Y; Qin Z; Ji J; Yang R; Zhang X; Li Y; Yin L; Pu Y; Li X
    J Drug Target; 2014 May; 22(4):352-64. PubMed ID: 24405019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Survivin small interfering RNA suppresses the growth of adenoid cystic carcinoma cell xenografts in vivo].
    Yang J; Wang X; Xu B; Xiong Y
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2009 Aug; 27(4):433-5. PubMed ID: 19769267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of human metastatic transitional cell carcinoma of the bladder in a murine model with the anti-vascular endothelial growth factor receptor monoclonal antibody DC101 and paclitaxel.
    Inoue K; Slaton JW; Davis DW; Hicklin DJ; McConkey DJ; Karashima T; Radinsky R; Dinney CP
    Clin Cancer Res; 2000 Jul; 6(7):2635-43. PubMed ID: 10914704
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction of apoptosis by survivin silencing through siRNA delivery in a human breast cancer cell line.
    Montazeri Aliabadi H; Landry B; Mahdipoor P; Uludağ H
    Mol Pharm; 2011 Oct; 8(5):1821-30. PubMed ID: 21838308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced Lysosomal Escape of pH-Responsive Polyethylenimine-Betaine Functionalized Carbon Nanotube for the Codelivery of Survivin Small Interfering RNA and Doxorubicin.
    Cao Y; Huang HY; Chen LQ; Du HH; Cui JH; Zhang LW; Lee BJ; Cao QR
    ACS Appl Mater Interfaces; 2019 Mar; 11(10):9763-9776. PubMed ID: 30776886
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lentivirus-mediated siRNA targeting VEGF inhibits gastric cancer growth in vivo.
    Sun P; Yu H; Zhang WQ; Hu M; Lv R
    Oncol Rep; 2012 Nov; 28(5):1687-92. PubMed ID: 22895814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. siRNA-mediated inhibition of antiapoptotic genes enhances chemotherapy efficacy in bladder cancer cells.
    Kunze D; Erdmann K; Froehner M; Wirth MP; Fuessel S
    Anticancer Res; 2012 Oct; 32(10):4313-8. PubMed ID: 23060552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.